Ormeci, N. Et Al. 2019. Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4 , 534-539.

Ormeci, N., Sezgin, O., Karaali, R., AYGEN, B., Turan, D., Yaras, S., ... Erdem, I.(2019). Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4, 534-539.

Ormeci, Necati Et Al. "Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences," EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4, 534-539, 2019

Ormeci, Necati Et Al. "Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4, pp.534-539, 2019

Ormeci, N. Et Al. (2019) . "Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4, pp.534-539.

@article{article, author={Necati Ormeci Et Al. }, title={Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences}, journal={EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY}, year=2019, pages={534-539} }